Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD

NCT04016779 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

374

Enrollment

INDUSTRY

Sponsor class

Conditions

Attention-Deficit/Hyperactivity Disorder (ADHD)

Interventions

DRUG: Placebo
DRUG: SPN-812

Sponsor

Supernus Pharmaceuticals, Inc.